Table 1 Clinical priority areas used to measure primary outcomes.
Clinical area | Expected changes in intervention group |
|---|---|
Asthma | ↓ short acting beta-agonists ↑ long-acting beta-agonists ↑ inhaled corticosteroids (decreased dose of steroids over time i.e. back titration or combinations of LABA & corticosteroids) |
Depression | ↑ SSRIs, ↑ SNRIs ↓ TCAs; |
Hypertension | ↑ diuretics ↓ other antihypertensives |
Upper respiratory tract infection | ↓ antibiotics and ↑ appropriate antibiotics |
Immunisation/vaccination | Higher rate of immunization and closer compliance with schedule. |
Lipid disorders | ↑ Statins, |
Type 2 Diabetes | ↑ glitazones ↑ metformin ↑ insulin ↓ sulfonylureas |
Non-inflamatory musculoskeletal including osteoarthritis | ↑ paracetamol ↓ NSAIDs ↓ Cox-2 inhibitors |